ATE221573T1 - Neue amyloid-precursor-proteine und verfahren zur deren verwendung - Google Patents

Neue amyloid-precursor-proteine und verfahren zur deren verwendung

Info

Publication number
ATE221573T1
ATE221573T1 AT93105718T AT93105718T ATE221573T1 AT E221573 T1 ATE221573 T1 AT E221573T1 AT 93105718 T AT93105718 T AT 93105718T AT 93105718 T AT93105718 T AT 93105718T AT E221573 T1 ATE221573 T1 AT E221573T1
Authority
AT
Austria
Prior art keywords
methods
amyloid precursor
polypeptides
precursor proteins
recombinant
Prior art date
Application number
AT93105718T
Other languages
English (en)
Inventor
Michael Peter Vitek
Jack Steven Jacobsen
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE221573T1 publication Critical patent/ATE221573T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/839—Nerves; brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93105718T 1992-05-01 1993-04-07 Neue amyloid-precursor-proteine und verfahren zur deren verwendung ATE221573T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87767592A 1992-05-01 1992-05-01

Publications (1)

Publication Number Publication Date
ATE221573T1 true ATE221573T1 (de) 2002-08-15

Family

ID=25370482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93105718T ATE221573T1 (de) 1992-05-01 1993-04-07 Neue amyloid-precursor-proteine und verfahren zur deren verwendung

Country Status (14)

Country Link
US (4) US5656477A (de)
EP (1) EP0584452B1 (de)
JP (1) JP3937459B2 (de)
KR (1) KR100330830B1 (de)
AT (1) ATE221573T1 (de)
AU (1) AU667895B2 (de)
CA (1) CA2095421C (de)
DE (1) DE69332163T2 (de)
DK (1) DK0584452T3 (de)
ES (1) ES2182823T3 (de)
NZ (1) NZ247499A (de)
PT (1) PT584452E (de)
TW (1) TW327194B (de)
ZA (1) ZA933084B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0613560B2 (de) * 1991-11-12 2006-06-21 Prana Biotechnology Ltd Verfahren zur bestimmung und behandlung von alzheimer-krankheit
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
EP0866805A1 (de) * 1995-12-12 1998-09-30 Karolinska Innovations AB Peptide, das die KLVFF Sequenz von beta-Amyloid bindet
AU723585B2 (en) * 1996-03-28 2000-08-31 Trustees Of Boston University Methods of modulating melanin synthesis
AU719038B2 (en) 1996-03-29 2000-05-04 Trustees Of Boston University Methods for diagnosing and treating Alzheimer's disease
DE19641180A1 (de) * 1996-09-24 1998-03-26 Schering Ag Verfahren zur Darstellung von APP-Sekretase Modulation und deren Verwendung als Mittel zur Behandlung der Alzheimer'schen Erkrankung
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) * 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
US7799535B1 (en) 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
KR20070013361A (ko) * 1998-09-24 2007-01-30 파마시아 앤드 업존 캄파니 엘엘씨 알츠하이머병 세크레타제
DE19856261C1 (de) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
US6518011B1 (en) * 1999-01-13 2003-02-11 Bristol-Myers Squibb Company Method for screening compounds to identify beta-amyloid production modulators
US6593512B1 (en) 1999-03-03 2003-07-15 Cognosci, Inc. Transgenic mouse expressing human tau gene
US7060670B1 (en) 1999-05-05 2006-06-13 Neurochem (International) Limited Stereoselective antifibrillogenic peptides and peptidomimetics thereof
FR2796952B1 (fr) 1999-07-30 2003-08-15 Centre Nat Rech Scient Nouvelles applications de peptides issus du domaine cytoplasmique du precurseur de la proteine amyloide
CA2395926A1 (en) * 1999-12-28 2001-07-05 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
CN1315353A (zh) * 2000-03-24 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人淀粉样糖蛋白9和编码这种多肽的多核苷酸
US6713276B2 (en) * 2000-06-28 2004-03-30 Scios, Inc. Modulation of Aβ levels by β-secretase BACE2
CA2438661C (en) * 2001-02-15 2011-05-31 University Of Chicago Yeast screens for agents affecting protein folding
EP1793001B1 (de) * 2001-02-15 2011-11-09 The University of Chicago Verfahren zum Nachweis in Hefe für mittels die Proteinfaltung beeinflussen
US6815175B2 (en) * 2001-03-16 2004-11-09 Cornell Research Foundation, Inc. Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
US7939641B2 (en) * 2002-04-09 2011-05-10 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
EP1523499A2 (de) * 2002-07-24 2005-04-20 Innogenetics N.V. Fragmente von beta-amyloid als angriffspunkt einer impfung gegen alzheimersche krankheit
EP1633786A4 (de) * 2002-10-09 2007-07-25 Rinat Neuroscience Corp Verfahren zur behandlung der alzheimer-krankheit mit antikörpern gegen amyloid-beta-peptid und zusammensetzungen daraus
WO2004093790A2 (en) * 2003-04-16 2004-11-04 Whitehead Institute For Biomedical Research Yeast ectopically expressing abnormally processed proteins and uses therefor
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20050112696A1 (en) * 2003-11-25 2005-05-26 The University Of Texas Southwestern Medical Center Compositions, methods and assays related to secretase cleavage specificity
GEP20115195B (en) * 2004-07-30 2011-04-11 Rinat Neuroscience Corp Antibodies directed against amyloid-beta peptide and use thereof
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
PE20061323A1 (es) 2005-04-29 2007-02-09 Rinat Neuroscience Corp Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
WO2008127251A1 (en) * 2006-05-05 2008-10-23 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Reversible inhibition of pyramidal gap junction activity
BRPI0910550A2 (pt) * 2008-04-30 2015-09-29 Novartis Ag ensaio para confôrmeros patogênicos
KR101825041B1 (ko) * 2016-04-07 2018-02-02 주식회사 바이오솔루션 물질 p를 포함하는 상처치유용 약학 조성물
CN116203242B (zh) * 2022-09-02 2025-08-05 中国农业科学院油料作物研究所 一种食用植物油中主要危害因子快速检测试纸条及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274826B1 (de) * 1986-11-17 1998-08-12 Scios Inc. Rekombiniertes Alzheimer Amyloid-Protein
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US4864859A (en) * 1988-07-25 1989-09-12 Allied-Signal Inc. Method for dynamically balancing a mechanism having a high speed rotating component
WO1990001540A1 (en) * 1988-08-11 1990-02-22 California Biotechnology Inc. Method for stabilizing heterologous protein expression and vectors for use therein
EP0447836A3 (en) * 1990-03-12 1991-10-02 American Cyanamid Company Amyloid peptide precursor rna
EP0451700A1 (de) * 1990-04-10 1991-10-16 Miles Inc. Rekombinante APP Minigene zur Expression in Transgen-Mäusen als Alzheimer-Krankheitsmuster
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein

Also Published As

Publication number Publication date
CA2095421A1 (en) 1993-11-02
ES2182823T3 (es) 2003-03-16
JP3937459B2 (ja) 2007-06-27
JPH07132094A (ja) 1995-05-23
KR100330830B1 (ko) 2002-11-23
EP0584452B1 (de) 2002-07-31
NZ247499A (en) 1996-04-26
DE69332163D1 (de) 2002-09-05
ZA933084B (en) 1993-11-24
US5656477A (en) 1997-08-12
AU3835893A (en) 1993-11-04
EP0584452A1 (de) 1994-03-02
AU667895B2 (en) 1996-04-18
US5693478A (en) 1997-12-02
PT584452E (pt) 2002-12-31
TW327194B (en) 1998-02-21
KR930023460A (ko) 1993-12-18
DK0584452T3 (da) 2002-11-18
DE69332163T2 (de) 2003-02-27
CA2095421C (en) 2008-11-18
US5703209A (en) 1997-12-30
US5652092A (en) 1997-07-29

Similar Documents

Publication Publication Date Title
DE69332163D1 (de) Neue Amyloid-Precursor-Proteine und Verfahren zur deren Verwendung
ATE140960T1 (de) Verfahren zur herstellung von zellen, die stabil integrierte fremde dns mit hoher kopiezahl enthalten, durch dieses verfahren hergestellte zellen und verwendung dieser zellen zur herstellung von durch diese fremde dns kodierten polypeptiden
ATE91716T1 (de) Verfahren zur herstellung vielkettige polypeptide oder proteine.
DE3781765D1 (de) Verfahren zur herstellung eines polypeptides.
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
BR9406715A (pt) Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-11) polipeptideo de proteina-11 morfogenética de osso purificada (BMP-11) e molécula de DNA quimérica
BR9406716A (pt) Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-10) polipeptideo de proteina-10 morfogenética de osso purificada (BMP-10) e molécula de DNA quimérica
DE60137847D1 (de) Eg-vegf nukleinsäuren und polypeptide und verfahren zur deren verwendung
FI875427A0 (fi) Menetelmä valmistaa hevosen -interferonia
ATE417063T1 (de) Sekretierte transmembranproteine und dafür kodierende nukleinsäuren
DK1205546T3 (da) Polypeptider og nucleinsyrer kodende derfor
ATE221082T1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä- b zellen und sein gen
DE3789552D1 (de) Licht-induzierbarer promotor.
ATE415422T1 (de) Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren
ATE291085T1 (de) Polypeptide und dafür kodierende nukleinsäure
PT1207168E (pt) Polipeptidos e acidos nucleicos que os codificam
PT1251173E (pt) Polipeptidos transmembranares e excretados e acidos nucleicos que os codificam
DK1241251T3 (da) Humant prostasin-lignende protein og nukleinsyrer kodende for samme
ATE282047T1 (de) Polypeptide und dafür kodierende nukleinsäure
DK1241252T3 (da) Nucleinsyrer, der opformeres i tumorer samt relaterede materialer og fremgangsmåder
ATE300553T1 (de) Sekretiertes polypeptide und dafür kodierende nukleinsäuren
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor
ATE268819T1 (de) Pro241 polypeptide und dafür kodierende nukleinsäuren
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette
PT1241185E (pt) Acido nucleico que e amplificado em tumores humanos e materiais e metodos relacionados

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0584452

Country of ref document: EP

REN Ceased due to non-payment of the annual fee